Journal of Vaccines & Vaccination

International Conference & Exhibition on Vaccines & Vaccination

22-24 Nov 2011 Philadelphia Airport Marriott, USA

Scientific Tracks Abstracts

• Prevalence of ESBL Escherichia coli in urinary tract infections

  Wanda C. Reygaert

  PDF HTML

• Rotavirus vaccine trials in bangladesh: Findings and lessons learned from phase I to IV studies

  K Zaman

  PDF HTML

• Antimicrobial resistance surveillance for nosocomial pathogens

  Olga Perovic

  PDF HTML

• Molecular studies on drug resistant malaria in India

  Y.D. Sharma

  PDF HTML

• Antimicrobial resistance among nosocomial isolates in a public hospital in Peru

  Yuri Garcia Cortez, Raul Montalvo, Ruben Dario Vasquez, Jaime Alvarezcano

  PDF HTML

• Globalization of antimicrobial resistance: Challenges and response in developing world

  Dave N G, Trivedi A V, Jani V R, Raval D A, Mevada M S and Dave S M

  PDF HTML

• Computer aided docking studies of some antimicrobial agents

  Jignasa K. Savjani and Anuradha K. Gajjar

  PDF HTML

• Comparative pharmacodynamics of ceftobiprole, daptomycin, linezolid, telavancin, tigecycline, and vancomycin in the treatment of methicillin resistant staphylococcus aureus: a monte carlo simulation Analysisd

  Ahmed H. Salem, Ehab A. Noreddin, George G. Zhanel, Ayman M. Noreddin

  PDF HTML

• Impediments to the rational design of a structure-based HIV-1 vaccine

  Marc H.V. Van Regenmortel

  PDF HTML

• Increased efficacy of BCG vaccines against experimental tuberculosis through genetic engineering of Th1 driving and immune-modulatory peptide epitopes

  Chinnaswamy Jagannath

  PDF HTML

• Longitudinal surveillance on the antibody level and incidence of adult Measles in Hongkou District of Shanghai, China

  Xiaohua Qian

  PDF HTML

• Polyclonal tregs enhance vaccine-induced immune responses by modulating the traffi cking of antigen-specifi c T cells

  Silvia Vendetti

  PDF HTML

• Epitope based vaccine design against Japanese encephalitis virus.

  Bhawna Rathi

  PDF HTML

• High throughput computational genome wide prediction and mapping of epitopes in severe acute respiratory syndrome coronavirus

  Pallavi Somvanshi and B.N. Mishra

  PDF HTML

• Protein- and DNA-based epitope vaccines for Alzheimer's disease

  Michael G. Agadjanyan

  PDF HTML

• Novel strategy for oral vaccine against pathogens

  Mansour Mohamadzadeh

  PDF HTML

• Quality control for malaria subunit vaccines

  Daming Zhu

  PDF HTML

• Safety nasal vaccination of ha vaccine with a potent mucosal antigen vehicle sf-10, mimicking pulmonary surfactant

  Hiroshi Kido, Dai Mizuno, Takashi Kimoto, Takuya Kunimi and Shinji Ono

  PDF HTML

• Malaria vaccine development: The Plasmodium falciparum serine repeat antigen

  Toshihiro Horii

  PDF HTML

• Development of an experimental vaccine against Plasmodium yoelii infection based on MAEBL-M2 domain in DNA (Prime)-Protein (Boost) immunization regimen

  Fabio T. M. Costa

  PDF HTML

• Studies on the development of the ovaries of the malaria mosquitoes (Anopheles pharoensis)

  Abeer S. Yamany

  PDF HTML

• Studies on the development of the ovaries of the malaria mosquitoes (Anopheles pharoensis)

  Abeer S. Yamany

  PDF HTML

• LMusosal vaccination of canine infl uenza H3N2 virus and comparison of effi cacy with conventional vaccines

  Daesub Song, Jeongki Kim, Haryoung Poo, Hyoungjoon Moon and Bokyu Kang

  PDF HTML

• Granulysin is a cytotoxic and proinfl ammatory effector molecule

  Veronica E. Calderon, Ediane Silva, Lorena Santos, W. Ray Waters, Mitchell V Palmer, Tyler C. Thacker, William R. Jacobs Jr., Michelle H. Larsen, Catherine Vilcheze, and D. Mark Estes

  PDF HTML

• Hepatitis A Vaccination in healthcare workers

  Praveen Guturu, Luca Cicalese, and Andrea Duchini

  PDF HTML

• Improvement in antihepatitis C virus resistance with ribavirin and pegylated- interferon-alpha 2b using an

  Yutaka Kishida

  PDF HTML

• MHC Class I TCR driven CD4+ antitumor T Cells for cancer immunotherapy.

  Arvind Chhabra

  PDF HTML

• Semiallogenic vaccines for the treatment of cancer and neurological disorders

  Mark S. Kindy

  PDF HTML

• Effi cacy of a mixture of synthetic peptides overlapping the conserved CBD1 epitope in gp41 of HIV- 1 to protect against SHIV162P3 rectal challenge in cynomolgus macaques

  Ara Hovanessian

  PDF HTML

• Mimotopes selected with neutralizing antibody against multiple subtypes of infl uenza A

  Yanwei Zhong, Jiong Cai, Chuanfu Zhang, Lu Liu, Dongqing Zhou, JiaqiHan, Shishu Zhu, Hongfei Zhang, Hongbin Song, Dongping Xu

  PDF HTML

• Prevention of estrogenindependent breast cancer using her family targeted dendritic cell vaccines

  Brian J Czern

  PDF HTML

• Immunization program in the largest U.S. jail: Protecting the highest risk individuals against infl uenza and hepatitis

  Mark Malek, John Costumbrado, Garrett Cox, Armidia Miranda RN, A. Nelson El Amin and Ali Stirland

  PDF HTML

• Pork industry intensifi cation and the changing ecology and epidemiology of swineorigin infl uenza

  Michael Greger

  PDF HTML

• Vaccination of lactating dairy cows for the prevention of afl atoxins carry over in the milk

  Luciano Polonelli

  PDF HTML

• Recombinant mycobacterium heat shock protein-70 (rHSP- 70) TLR-2, TLR-4 agonist as a perspective tool for protection against bacterial and viral infections and tumors in mice

  Vorobiev D.S., Semenova I.B

  PDF HTML

• Challenges in the development of vaccines for leptospirosis in the philippines

  Nina G. Gloriani, Lolita L. Cavinta, Rubelia A. Baterna, Crystal Amiel Estrada, Anna Kriselda Rivera, Shin-ichi Yoshida, Sharon Y.A.M. Villanueva and Yasutake Yanagihara

  PDF HTML

• Optimization of anti-cysticercosis S3Pvac vaccine and experiences on its extensive application in a taeniasis-cysticercosis control program

  Edda Sciutto

  PDF HTML

• BHV-1 gG and tk deletion decreased viral virulence, provided protection, and improved IFN-β production

  Guo Aizhen

  PDF HTML

• Bacterial ghost: Novel approach of vaccine delivery in aquaculture

  Sontakke U.B, Muneendra Kumar, S.K. Asraf Houssain, Sagar Jadhav, Patil C.S and Harjit Kaur

  PDF HTML

• Production of tissue culture anti rabies vaccine for human use in Nepal

  Ganesh Raj Pant

  PDF HTML

• Decreased Leishmania DNA load and increased mRNA IFN-g levels occur in leishmaniotic dogs vaccinated with a novel DNA vaccine for visceral leishmaniasis

  Laura Manna

  PDF HTML

• Display of VP1 on the surface of baculovirus and its immunogenicity against human enterovirus 71 in mice

  Jimmy Kwang

  PDF HTML

• TcVac2R (DNA/protein), but not TcVac1R (DNA/ DNA), is protective against T. cruzi infection and Chagas disease in dogs

  Nisha Jain Garg, Shivali Gupta, and Juan Carlos Vazquez-Chagoyan

  PDF HTML

• In situ immunization followed by adoptive cellular therapy against breast cancer

  Masoud H Manjili

  PDF HTML

• Carbohydrate based vaccines for the treatment of cancer

  Livingston P.O and Ragupathi G

  PDF HTML

• Therapeutic vaccines using immune regulatory functions of invariant natural killer T (iNKT) cells

  Yasuyuki Ishi

  PDF HTML

• Synthetic virus-like particles in vaccine design

  Arin Ghasparian

  PDF HTML

• Pilot prospective multicentric case control study of severe pneumonia in children under fi ve years of age

  Gl�ucia Paranhos-Baccal�

  PDF HTML

• VLPs display technology a step towards effi cient vaccination platform using stable insect cell line and silkworms

  Vipin Kumar Deo, Yoshitaka Tsuji, Tomomi Yasuda, Tatsuya Kato, Naonori Sakamoto, Hisao Suzuki and Enoch Y Park

  PDF HTML

• Pharmaceutical and immunological evaluation of mucoadhesive nanoparticles based delivery system(s) administered Intranasally

  Sharad Mangal, Jaganathan KS, Raman Rao

  PDF HTML

• Nanoparticle-mediated delivery of siRNA targeting the HIV-1 coreceptor CXCR4 in HeLa-derived cells

  Carole Lavigne, Arnold J, Kell, Alain R. Thierry, Michael L. Barnes, Niranjala Gajanayaka, Kathryn Slater

  PDF HTML

• Synthetic QS-21 and Rationally Designed QS- 21 Analogs

  Jeffrey R Gardner

  PDF HTML

• HZ incidence rates increase: Is this due to varicella vaccine use in children?

  Barbara P. Yawn, Peter Wollan and Marge Kurland RN

  PDF HTML

• The innate immune response to the plague vaccine in vaccination and protection

  Kei Amemiya

  PDF HTML

• Tailoring induction of CD8 T cell quantity and phenotype by vaccine adjuvants

  Lakshmi Krishnan, Felicity C Stark, Valeria Alcon, Fanny Tzelepis, G. Dennis Sprott and Subash Sad

  PDF HTML

• Protein transfer approach to cancer vaccine development

  Periasamy Selvaraj

  PDF HTML

• Development of dendritic cell-based tumor vaccines with high effi cacy by targeting the negative regulators of DC functions: Guiding the 'misguided'

  Fang-Ping Huang

  PDF HTML

• Vaccine therapy for lymphomas: From bench to bedside and back

  Sattva S. Neelapu

  PDF HTML

• Construction and immunological study on recombinant multiepitope DNA vaccine of H3/H1subtypes of infl uenza virus

  Huijun Lu, Lei Tan, Mingyao Tian and Ningyi Jin

  PDF HTML

• Antigen-specifi c therapy of eae via intranasal delivery of fi lamentous phage displaying a myelin immunodominant epitope

  Beka Solomon

  PDF HTML

• Rebounding of dendritic cells post chemotherapy: Implication for cancer immunotherapy

  Mohamed L. Salem

  PDF HTML

• Pathogen-associated molecular patterns on biomaterials: A paradigm for engineering new vaccines

  Tarek M. Fahmy

  PDF HTML

• Identifi cation of immunogenic proteins and generation of antibodies by phage display

  Andre Franzel and Michael Hust

  PDF HTML

• Effi cacy of edwardsiella tarda, streptococcus iniae, strpetococcus parauberis, vibrio anguillarum, and tenacibaculum maritimum combined vaccine for cultured olive floundery

  Bokyu Kang

  PDF HTML

• Why parents under vaccinate their children and how can practitioners reduce the incidence of vaccination exemptions

  Chad Rittle

  PDF HTML

• Mucosal immunization with an unadjuvanted vaccine that targets S. pneumoniae PspA to human Fc?RI protects against Pneumococcal infection via complement- and Lactoferrin-Mediated Bactericidal Activity

  Edmund J. Gosselin, Constantine Bitsaktsis and Bibiana Iglesias

  PDF HTML

• Chitosan-based particles as adjuvants for Hepatitis B needle-free vaccines?

  Olga Borges

  PDF HTML

• Colonisation endpoints in vaccine trials - design questions for Streptococcus pneumoniae

  Kari Auranen

  PDF HTML

• Identifi cation of novel Leishmania donovani antigens for development of second generation vaccine against Leishmaniasis

  Sudipta Bhowmick and Nahid Ali

  PDF HTML

• Role of immune modulator KMK as a vaccine adjuvant

  Farah Khan

  PDF HTML

• Novel vaccine candidates for an improved a cellular vaccine of B. pertussis

  Mar�a Eugenia Rodriguez

  PDF HTML

• Malaria vaccine related studies in Iran: Past, present and future

  Saber Gholizadeh

  PDF HTML

• Adjuvant-enhanced antibody and cellular responses to recombinant FhSAP2 correlates with protection of mice to Fasciola hepatica

  Ana M. Espino and Fracheska Rivera

  PDF HTML

• Non-infl ammatory adjuvant for cutaneous vaccination

  Mei X. Wu, Xinyuan Chen and Richard R. Anderson

  PDF HTML

• Mechanism of action of the oil in water emulsion vaccine adjuvant MF59

  Ennio De Gregorio

  PDF HTML

• Recent advances in high throughput screening methods for formulation development of vaccines

  S. Fernando Ausar

  PDF HTML

• Evaluating the potential of an In vitro expression system in generating diffi cult to-express Hc botulinum vaccines

  R. Zichel, A. Mimran, E. Diamant, A. Keren, A. Barnea, I. Steinberger- Levy, D. Marcus, A. Turgeman, and S. Reuveny

  PDF HTML

• Recent advances in high throughput screening methods for formulation development of vaccines

  S. Fernando Ausar

  PDF HTML

• Evaluating the potential of an In vitro expression system in generating diffi cult to-express Hc botulinum vaccines

  R. Zichel, A. Mimran, E. Diamant, A. Keren, A. Barnea, I. Steinberger- Levy, D. Marcus, A. Turgeman, and S. Reuveny

  PDF HTML

• Vaccinia virus as recombinant viral vectors: are we ready to use them? Insights from the field and from the lab

  Flavio Guimaraes da Fonseca, Lorena Falabella Daher de Freitas and B�rbara Resende Quinan

  PDF HTML

• Acceptability of human papillomavirus vaccine among women in China: A literature review of surveys among 23,700 women

  Lina Hu and Lei Yu

  PDF HTML

• Molecular epidemiology, vaccine matching, and assessment of risk factors of foot-and mouth disease virus circulating in Ethiopia

  Haileleul Negussie, Gelagay Ayelet, Shiferaw JT and Esayas Gelaye

  PDF HTML

• Cells need safety valves

  Antoine Danchin

  PDF HTML

• Molecular epidemiology, vaccine matching, and assessment of risk factors of foot-and mouth disease virus circulating in Ethiopia

  Haileleul Negussie, Gelagay Ayelet, Shiferaw JT and Esayas Gelaye

  PDF HTML

• Cells need safety valves

  Antoine Danchin

  PDF HTML

• Predictors of defaulting from completion of child immunization in south Ethiopia, A case control study

  Henok Tadesse Ayele, Amare Deribew, Mirkuzie Woldie

  PDF HTML

• Computational model for proliferation-able muscle stem cells

  Obaidul Malek, Anastasios Venetsanopoulos, Thomas Hawke, Laila Alamgir, Sri Krishnan and Javad Alirezaie

  PDF HTML